Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morlat

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
HIV Medicine|December 20, 2014
Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 surveyE Rosenthal, C Roussillon, D Salmon-Céron, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 4, 2015
HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patientsD Salmon, F Bani-Sadr, C Gilbert, et al.
HIV Medicine|December 17, 2009
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, FranceE K Déti, R Thiébaut, F Bonnet, et al.
La Revue De Medecine Interne|January 1, 1997
[Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects]C Rancinan, P Morlat, G Chêne, et al.
Epidemiology and Infection|April 9, 2005
Management of chronic hepatitis C in French departments of internal medicine and infectious diseasesP Cacoub, I Goderel, P Morlat, et al.
BMJ (Clinical Research Ed.)|August 24, 1996
Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en AquitaineF Saillour, F Dabis, M Dupon, et al.
AIDS (London, England)|November 1, 1996
Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial GroupF Derouin, C Leport, S Pueyo, et al.
Journal Des Maladies Vasculaires|January 1, 1996
[Aortic aneurysms due to Yersinia enterocolitica: three new cases and a review of the literature]P Mercié, P Morlat, A N'Gako, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1997
Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial GroupS Pueyo, L R Salmi, G Chêne, et al.
Gastroenterologie Clinique Et Biologique|August 30, 2000
[Multicenter study of intrafamilial transmission of hepatitis C virus in human immunodeficiency virus infection]C Huët, F Dabis, F Saillour, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
HIV Medicine|December 20, 2014
Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 surveyE Rosenthal, C Roussillon, D Salmon-Céron, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 4, 2015
HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patientsD Salmon, F Bani-Sadr, C Gilbert, et al.
HIV Medicine|December 17, 2009
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, FranceE K Déti, R Thiébaut, F Bonnet, et al.
La Revue De Medecine Interne|January 1, 1997
[Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects]C Rancinan, P Morlat, G Chêne, et al.
Epidemiology and Infection|April 9, 2005
Management of chronic hepatitis C in French departments of internal medicine and infectious diseasesP Cacoub, I Goderel, P Morlat, et al.
BMJ (Clinical Research Ed.)|August 24, 1996
Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en AquitaineF Saillour, F Dabis, M Dupon, et al.
AIDS (London, England)|November 1, 1996
Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial GroupF Derouin, C Leport, S Pueyo, et al.
Journal Des Maladies Vasculaires|January 1, 1996
[Aortic aneurysms due to Yersinia enterocolitica: three new cases and a review of the literature]P Mercié, P Morlat, A N'Gako, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1997
Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial GroupS Pueyo, L R Salmi, G Chêne, et al.
Gastroenterologie Clinique Et Biologique|August 30, 2000
[Multicenter study of intrafamilial transmission of hepatitis C virus in human immunodeficiency virus infection]C Huët, F Dabis, F Saillour, et al.
Pageof 18